The landscape of drug treatment for MASH is rapidly evolving, with two licensed drugs, resmetirom and semaglutide, and a growing array of additional therapeutic options demonstrating promising efficacy
In mouse models of highfat dietinduced liver steatosis, it significantly inhibits hepatic NNMT activity, reduces NAM methylation, increases NAD+ and SAM levels, enhances mitochondrial fatty acid oxidation, reduces hepatic triglyceride and lipid accumulation, lowers lipotoxicity markers (e.g., malondialdehyde, transaminases), improves hepatocellular injury, and reverses steatosis
HOW TO USE Step 1 - Wash your face with a facial cleanser Step 2 - Mix the ampoule and primer in a 1:1 ratio and apply it evenly on your skin
A BMI of 27 or above, accompanied by at least one weight-related health condition, such as high blood pressure, high cholesterol, or cardiovascular disease
Hanna Lantto: nothing to disclose